Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.88+0.48 (+34.29%)
Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%
Cadrenal Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cadrenal Therapeutics's enterprise value was $2.10M on Nov 11, 2026, against $15.48M a year earlier. Over the last 4 years it ranged from -$3.12M to $23.85M, with a median of $10.11M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.10M | -79.2% |
| 2025 | Dec 31, 2025 | $10.11M | -25.3% |
| 2024 | Dec 31, 2024 | $13.53M | +2473.7% |
| 2023 | Dec 29, 2023 | $525.57K | – |
See a number that looks wrong?